Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.

OBJECTIVE Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor that arises from the intrahepatic bile ducts. Although the pathologic and imaging features of ICC have been clearly identified, recent updates have addressed the pathologic classification and imaging features of ICC using new imaging techniques. First, a proposed new pathologic ICC subclassification includes perihilar large duct and peripheral small duct ICCs. Second, advanced MR-based imaging features of ICC, such as hepatobiliary phase imaging using hepatocytespecific contrast material and DWI, have recently been described. These imaging features are important when differentiating ICCs from hepatocellular carcinomas. Finally, some imaging features of ICC, such as prominent arterial enhancement or degree of delayed enhancement, exhibit potential as prognostic imaging biomarkers. CONCLUSION Comprehensive and updated knowledge of ICC is necessary for accurate diagnosis and could facilitate prediction of clinical outcomes for patients with ICC.

[1]  M. Reiser,et al.  Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI. , 2013, European journal of radiology.

[2]  Eun Sun Lee,et al.  Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging , 2016, European Radiology.

[3]  Sang Min Lee,et al.  Diagnostic accuracy of liver imaging reporting and data system (LI‐RADS) v2014 for intrahepatic mass‐forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid‐enhanced MRI , 2016, Journal of magnetic resonance imaging : JMRI.

[4]  Jae Young Lee,et al.  Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. , 2007, AJR. American journal of roentgenology.

[5]  M. Unno,et al.  Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation , 2011, Abdominal Imaging.

[6]  H. Honda,et al.  Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. , 2006, Radiology.

[7]  Yong Eun Chung,et al.  Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI , 2016, European Radiology.

[8]  G. Aranha,et al.  Gastric linitis plastica is not a surgical disease. , 1989, Surgery.

[9]  N. Hayabuchi,et al.  Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. , 1999, Journal of computer assisted tomography.

[10]  Myeong-Jin Kim,et al.  Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. , 2011, AJR. American journal of roentgenology.

[11]  M. C. Han,et al.  CT features of intraductal intrahepatic cholangiocarcinoma. , 2000, AJR. American journal of roentgenology.

[12]  J. Konishi,et al.  MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. , 2001, AJR. American journal of roentgenology.

[13]  B. Choi,et al.  Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes. , 2008, Clinical imaging.

[14]  Jae Young Lee,et al.  MR imaging findings of early bile duct cancer , 2008, Journal of magnetic resonance imaging : JMRI.

[15]  D. Choi,et al.  Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI , 2013, Abdominal Imaging.

[16]  T. Yoshikawa,et al.  Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? , 1998, Journal of surgical oncology.

[17]  Seung‐Mo Hong,et al.  Thread sign in biliary intraductal papillary mucinous neoplasm: a novel specific finding for MRI , 2016, European Radiology.

[18]  P. R. Ros,et al.  Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. , 1988, Radiology.

[19]  Y. Atomi,et al.  Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria , 2007, Modern Pathology.

[20]  M. Monden,et al.  Intrahepatic cholangiocarcinoma with marked hypervascularity , 1999, Abdominal Imaging.

[21]  Yoshihiko Maehara,et al.  Proposal of Progression Model for Intrahepatic Cholangiocarcinoma: Clinicopathologic Differences Between Hilar Type and Peripheral Type , 2007, The American journal of surgical pathology.

[22]  Jae Young Lee,et al.  CT Features of an Intraductal Polypoid Mass: Differentiation Between Hepatocellular Carcinoma With Bile Duct Tumor Invasion and Intraductal Papillary Cholangiocarcinoma , 2006, Journal of computer assisted tomography.

[23]  Young Kon Kim,et al.  Scirrhous Hepatocellular Carcinoma on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging: Emphasis on the Differentiation of Intrahepatic Cholangiocarcinoma , 2013, Journal of computer assisted tomography.

[24]  J. H. Lim,et al.  Intraductal papillary mucinous tumor of the bile ducts. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[25]  Young Kon Kim,et al.  Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma , 2013, Abdominal Imaging.

[26]  C. Yi,et al.  Radiological Spectrum of Intraductal Papillary Tumors of the Bile Ducts , 2002, Korean journal of radiology.

[27]  R. Manfredi,et al.  Magnetic resonance imaging of cholangiocarcinoma. , 2004, Seminars in liver disease.

[28]  G. Carpino,et al.  Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity. , 2012, World journal of gastrointestinal oncology.

[29]  Yasunori Sato,et al.  What Are the Precursor and Early Lesions of Peripheral Intrahepatic Cholangiocarcinoma? , 2014, International journal of hepatology.

[30]  W. Knight,et al.  Primary linitis plastica of the colon. Report of two cases and review of the literature , 1978, Cancer.

[31]  Y. Nakanuma,et al.  Pathologic classification of cholangiocarcinoma: New concepts. , 2015, Best practice & research. Clinical gastroenterology.

[32]  Y. Nakanuma,et al.  Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas , 2006, Hepatology.

[33]  Myeong-Jin Kim,et al.  Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. , 2013, AJR. American journal of roentgenology.

[34]  Yasunori Sato,et al.  Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. , 2009, World journal of hepatology.

[35]  M. Federle,et al.  Cholangiocarcinoma: delayed CT contrast enhancement patterns. , 1997, Radiology.

[36]  Jeong Min Lee,et al.  Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. , 2010, Radiology.

[37]  B. Choi,et al.  Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. , 2012, Radiology.

[38]  Masakazu Yamamoto,et al.  Mass‐forming intrahepatic cholangiocarcinoma with marked enhancement on arterial‐phase computed tomography reflects favorable surgical outcomes , 2011, Journal of surgical oncology.

[39]  H. Rhim,et al.  Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI. , 2012, Clinical radiology.

[40]  S. Park,et al.  Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT, endoscopic retrograde cholangiography and MR cholangiography , 2012, European Radiology.

[41]  Jae Young Lee,et al.  Differentiating malignant from benign common bile duct stricture with multiphasic helical CT. , 2005, Radiology.

[42]  C. Sirlin,et al.  Cirrhotic liver: What's that nodule? The LI‐RADS approach , 2016, Journal of magnetic resonance imaging : JMRI.

[43]  Sun-Whe Kim,et al.  Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma , 2000, Hepatology.

[44]  M. Tsuneyoshi,et al.  The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth. , 1999, The American journal of surgical pathology.

[45]  B. Choi,et al.  Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. , 2011, Radiology.

[46]  M. Matsuda,et al.  Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin , 2007, Hepatology.

[47]  Hyeon Je Cho,et al.  Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[48]  J. H. Lim,et al.  Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. , 2003, AJR. American journal of roentgenology.

[49]  S. Kitano,et al.  Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment , 1998, The British journal of surgery.

[50]  T. Nagayasu,et al.  Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma , 2008, Journal of surgical oncology.

[51]  J. Lee,et al.  Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection , 2013, Abdominal Imaging.

[52]  E. Merkle,et al.  Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging , 2015, European Radiology.

[53]  H. Ojima,et al.  Surgical Outcomes of the Mass-Forming plus Periductal Infiltrating Types of Intrahepatic Cholangiocarcinoma: A Comparative Study with the Typical Mass-Forming Type of Intrahepatic Cholangiocarcinoma , 2007, World Journal of Surgery.

[54]  Myung-Hwan Kim,et al.  International Consensus Diagnostic Criteria for Autoimmune Pancreatitis: Guidelines of the International Association of Pancreatology , 2011, Pancreas.

[55]  T. Nagayasu,et al.  Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics , 2013, Abdominal Imaging.

[56]  Masakazu Yamamoto,et al.  Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)". , 2014, International journal of clinical and experimental pathology.

[57]  Y. Oda,et al.  Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type , 2015, Journal of hepato-biliary-pancreatic sciences.

[58]  J. K. Lee,et al.  Papillary neoplasms of the bile duct that mimic biliary stone disease. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[59]  Jing Xu,et al.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. , 2010, World journal of hepatology.

[60]  Yoshihiro Sakamoto,et al.  Distinct Clinicopathologic and Genetic Features of 2 Histologic Subtypes of Intrahepatic Cholangiocarcinoma , 2016, The American journal of surgical pathology.

[61]  H. Ha,et al.  Malignant papillary neoplasms of the intrahepatic bile ducts: CT and histopathologic features. , 2000, AJR. American journal of roentgenology.